Marc Grasso serves as the Chief Financial Officer at Kyverna Therapeutics. Previously, they held the CFO position at Alector and Kura Oncology, along with significant roles in investment banking at Stifel and UBS. Marc was pivotal in expanding the biotechnology practice at various firms including Leerink Swann and Credit Suisse. They earned an M.D. from the Johns Hopkins University School of Medicine and an A.B. in molecular biology with honors from Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices